Pre-Stem Cell Transplant Treatment Regimen for AML, MDS - NCI

Pre-Stem Cell Transplant Treatment Regimen for AML, MDS - NCI

A Cancer Currents blog on a study suggesting that an intensive preparatory regimen should be used for younger patients with AML undergoing a stem cell transplant.

American Journal of Hematology, Blood Research Journal

Cancers, Free Full-Text

Frontiers Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS

Frontiers Milestones of Hematopoietic Stem Cell Transplantation – From First Human Studies to Current Developments

Stem Cell Transplant - Successful Treatment for Myelodysplastic Syndromes - CancerConnect

Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy - Transplantation and Cellular Therapy, Official Publication of the American Society for

Frontiers Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy

IJMS, Free Full-Text

Hematopoietic Stem Cell Transplantation (HSCT): Practice Essentials, Historical Background, Indications for HSCT

A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies

Frontiers Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimen: A Pilot Phase II Study

Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome - Wei - 2021 - Cancer Science - Wiley Online Library

Cancers, Free Full-Text